Margin of Safety

What $110.19 pays for

At $110.19 the equity is worth about $3.02 billion, or 15.3x the fiscal 2027 consensus. On a perpetuity discounted at 9%, that price embeds roughly 2.5% growth forever. The protection on offer is a 3.6% dividend, a 6.5% free cash flow yield and covenant headroom of roughly 90%. It is not a discount to asset value.

The multiples

Marzetti had 27,422,381 shares outstanding at 31 March 2026 [1]. At the 28 July 2026 close of $110.19 that is a market capitalisation of $3,021.7 million. The balance sheet behind it carried $218.4 million of cash, no borrowings, and $1,044.8 million of shareholders' equity at the same date [2] — the Bachan's purchase closed a month later, on 1 May 2026, for $400 million funded from cash and a $200 million term loan [3] [4].

Sources: share count and balance sheet from the Q3 FY2026 Form 10-Q [5]; price and consensus estimates as reported.

The full stack is below. Consensus for fiscal 2026 and 2027 comes from four to six contributing analysts — a thin panel, as Financials and Estimates established — so these are reference points, not precision instruments.

Source: derived from consensus estimates and the 27,422,381 shares outstanding at 31 March 2026 [6]; trailing column uses fiscal 2025 reported operating income of $220.3 million and depreciation of $62.2 million [7] [8].

Two features of that table matter more than the headline multiple. The free cash flow yield of 6.5% is real cash: fiscal 2025 operating cash flow was $261.5 million against $58.0 million of capital spending [9], and consensus has fiscal 2026 free cash flow at $197.8 million even with capital spending guided up to the $75 million to $85 million range [10]. And the dividend absorbs a little over half of that, not all of it. The board raised the quarterly rate to $1.00 on 19 November 2025 [11], the 63rd consecutive annual increase after the 62 recorded through fiscal 2025 [12], putting the fiscal 2026 payout at $3.95 a share against a fiscal 2025 rate of $3.75 [13].

What the de-rating did to the yield

The dividend yield moved further than the earnings multiple, which Business and De-Rating already tracked. The numerator has risen every year for six decades while the denominator fell by more than a third.

Source: derived from dividends declared per share in the consolidated statements of shareholders' equity and fiscal-year-end closing prices; fiscal 2026 uses the $3.95 declared rate [14] against the 28 July 2026 close.

Between fiscal 2017 and fiscal 2025 the yield sat in a 1.52% to 2.45% band. At $110.19 it is 3.58%, roughly double the nine-year average and above every year-end reading in the series. On the fiscal 2027 consensus rate of $4.15 it is 3.77%.

The growth the price embeds

A perpetuity is a crude model for a company with two segments and a licensing programme, and it should be read as a boundary rather than a valuation. What it supplies is the perpetual growth rate the current price implies.

Taking fiscal 2026 consensus free cash flow of $197.8 million as the base and discounting at 9%, the equity value is $197.8 million divided by (9% minus g). Solving for the current market capitalisation gives an implied perpetual growth rate of 2.45%. At an 8% discount rate it is 1.45%; at 10%, 3.45%.

Source: derived from consensus fiscal 2026 free cash flow of $197.8 million and 27,422,381 shares outstanding [15].

The grid places $110.19 between the 2% and 3% growth cases. For context, revenue compounded at 7.4% a year over the five years to fiscal 2025 and 4.4% over three; consensus has fiscal 2028 revenue growing 2.0% and earnings 2.8%, on a single contributing broker. The price is therefore below the historical growth rate and roughly at the consensus terminal rate. A zero-growth business on these assumptions is worth about $80 a share; a 4% grower is worth about $144, below the $159 consensus target price carried by the two buy and three hold ratings on the stock.

Two downside cases

The largest identifiable loss is not a recession. It is the Chick-fil-A relationship, which produced $548.2 million of net sales in fiscal 2025, 29% of the consolidated total [16], split between a Foodservice supply leg and an exclusive Retail licence that The Licensing Engine decomposed at roughly $401 million and $147 million respectively.

The Licensing Engine applies the fiscal 2025 segment margins to that split and puts about $31 million of segment operating income behind the Retail licence and about $49 million behind the supply leg.

Source: derived from fiscal 2025 segment operating margins [17] [18], Chick-fil-A net sales of $548.2 million [19], a 22% tax rate and 27,422,381 shares [20].

Losing the Retail licence alone costs about $0.88 of earnings per share and, at an unchanged 15x, about $15 of value. Losing the whole relationship costs $2.29 and, at a multiple that would almost certainly compress, takes the shares into the $60s to $70s. These estimates err in both directions: the $97.9 million of unallocated corporate expense reported for fiscal 2025 would not disappear with the sales, which makes them optimistic [21], while a manufacturer of this size would cut cost against a loss of that size, which makes them pessimistic. Neither leg is contractually protected — no brand licence agreement is filed as an exhibit anywhere in the corpus, so duration and renewal terms are unreadable from the public record.

The second downside case needs no event at all. If the base business simply does not grow — the fiscal 2026 experience extended indefinitely, with adjusted nine-month earnings per share flat year on year — the perpetuity grid puts the equity near $80, about 27% below the current price. That is the arithmetic cost of the plateau outcome.

Solvency, which is a separate question

Permanent loss of capital through insolvency is a separate risk from a de-rating, and it is worth measuring against the actual covenant terms rather than a leverage headline. The credit facility carries two financial covenants: an interest coverage ratio of not less than 2.5 to 1, measured as consolidated EBIT over consolidated interest expense, and a consolidated leverage ratio of not greater than 3.5 to 1, measured as consolidated net debt over consolidated EBITDA [22]. The agreement also lets the borrower elect a 4.00 to 1.00 leverage ceiling for the twelve months after a material acquisition, an election available no more than twice over the life of the facility [23].

Against those tests, consensus has fiscal 2026 net debt at $62 million and EBITDA at $304 million — leverage of 0.20x. EBITDA would have to fall roughly 94%, to about $18 million, before the 3.5x test binds at that debt level. On interest, $200 million drawn at a rate in the mid-5% range implies roughly $11 million of annual interest against EBIT near $234 million: about 21x cover, requiring an 88% collapse in EBIT to breach. The company itself said it exceeded the financial covenants by substantial margins at 30 June 2025 and expected to remain in compliance [24], and had no borrowings outstanding at 31 March 2026 [25].

Two qualifications belong next to that. The term loan matures five years after drawing, but springs forward to 6 March 2029 if the revolver has not been extended by 6 December 2028 to a date at least as long as the term loan, with commitments at least equal to the term loan balance [26]. And a lease commitment with fixed cash payments of approximately $159 million — fifteen years of warehousing space in Columbus, Ohio — sat off the balance sheet at 31 March 2026 and commences in fiscal 2027 [27]. That undiscounted commitment is four-fifths the size of the term loan and appears in none of the leverage arithmetic above. It is an operating obligation rather than debt, but a reader counting fixed claims should count it.

Asset backing is thinner than the solvency picture suggests. Shareholders' equity of $1,044.8 million includes $222.8 million of goodwill [28], leaving tangible book value near $30 a share, about 27% of the price — and the Bachan's purchase, at $400 million for a brand whose net sales for the twelve months to 31 December 2025 were approximately $87 million [29], will add a large intangible balance when the fiscal 2026 purchase price allocation is filed. This is not an asset play. The downside protection is the cash flow and the covenant headroom, not the book.

The peer check

Marzetti's multiple is not an outlier among packaged-food companies that fell in the same window.

Source: derived from reported financials in each company's latest annual filing and closing prices to 29 July 2026. Each multiple is struck on that company's latest reported fiscal year, so Marzetti appears at 18.1x on fiscal 2025 earnings of $6.07 [30] rather than 17.2x on the trailing twelve months. Kraft Heinz and Conagra reported net losses, so no multiple is shown.

Marzetti fell 40% over twelve months and trades at 18.1x trailing earnings. McCormick fell 29% and trades at 17.7x; Flowers Foods fell 54% and trades at 19.1x on collapsed earnings; Campbell's fell 31% and trades at 11.4x. Marzetti is the only name in the group combining positive three-year revenue growth, positive branded volume growth on the Circana benchmark it publishes (Category Tailwinds), and a net cash position before the Bachan's borrowing. It is also, on trailing earnings, among the more expensive.

The read, and what would change it

The evidence points to a business priced for roughly 2.5% perpetual growth, paying 3.6% in dividends and 6.5% in free cash flow to wait, on a balance sheet where insolvency requires something close to a 90% earnings collapse. That is a defensible entry price for a durable compounder that has stopped compounding — but it is not a large margin of safety, because the multiple sits mid-pack against peers facing the same volume problem, and the concentration risk that would do the most damage is not discounted at all. A licence loss takes the shares to the $60s or $70s from a price that assumes the licence persists.

The strongest fact against this read is the free cash flow itself. Consensus has it at $197.8 million in fiscal 2026 and $207.0 million in fiscal 2027, roughly 105% of net income in both years, on a company whose March 2026 quarter marked what management described on the call as the eleventh straight quarter of gross margin improvement, driven by procurement, manufacturing, value engineering and distribution savings rather than volume [31]. A business converting earnings to cash at that rate, with the dividend at 55% of it, does not need growth to be worth holding — it needs only to not shrink.

Three things would change the read. A price near $80 would put the zero-growth case in the price and turn the concentration risk into an asymmetry rather than an exposure. Evidence that Retail volumes have resumed growth — pounds shipped fell 5.6% in the March 2026 quarter [32] — would restore the 3% to 4% growth cases and with them roughly $10 to $34 a share of value on the grid above. And a Chick-fil-A licence renewal disclosed on terms, or a filed agreement, would remove the largest unbounded item in the downside. Against that, a second consecutive year of falling Retail volume, or the Bachan's purchase price allocation revealing an amortisation charge large enough to move fiscal 2027 earnings, would push the fair range toward the flat-forever case.